Search clinical trials for: Tobacco use disorder

Total 161432 results

Eli Lilly and Company

Completed

Raloxifene Use for The Heart

Cardiovascular Diseases | Breast Neoplasms

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer.

Genital Neoplasms, Female | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Pelvic Neoplasms

United States
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Eli Lilly and Company

Completed

An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Germany
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Inappropriate ADH Syndrome | Water Intoxication | Hyponatremias | Water-Electrolyte Imbalances

United States
Northeastern Ohio Universities College of Medicine
Pfizer; U.S. Army Medical Research and Development Command; Louis Stokes VA Medical... and other collaborators

Unknown

Restless Legs Syndrome Exercise Intervention

Restless Legs Syndrome | Insomnia
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company

Completed

Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder.

Attention Deficit Hyperactivity Disorder

Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company

Completed

Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma

Gastrointestinal Neoplasms

Korea, Republic of
Eli Lilly and Company

Completed

Teriparatide Use in Hip Replaced Subjects

Osteoporosis

Italy
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Depressive Disorder, Major

Belgium, Germany, France, Slovakia, Czech Republic, Finland
Eli Lilly and Company

Completed

A Study in People With Abnormal Fat Levels in the Blood

Dyslipidemia

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company

Completed

Efficacy Study of LY2422347 to Treat Insomnia

Sleep Initiation and Maintenance Disorders

United States
Eli Lilly and Company

Completed

Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD

Attention-Deficit/Hyperactivity Disorder | Comorbid Dyslexia

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Shaare Zedek Medical Center

Unknown

PAR Family Polymorphisms and Placental Invasion Disorders

Miscarriage, Recurrent | Premature Labor
Eli Lilly and Company

Completed

Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Attention-Deficit/Hyperactivity Disorder

Canada
Eli Lilly and Company

Completed

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Major Depressive Disorder

Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
University of Texas Southwestern Medical Center
Biogen

Completed

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

Multiple Sclerosis

United States
Geha Mental Health Center

Unknown

Reboxetine Treatment in Depressed Children and Adolescents an 8-Week, Open Study

Depression

Israel
Sheba Medical Center

Suspended

Simulation Training as a Tool to Decrease Occupational Stress in ICU Personnel

Education, Health

Israel
National Center for Complementary and Integrative...

Completed

Shamanic Healing for Women With Temporomandibular Joint Disorders (TMDs)

Temporomandibular Disorders

United States
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women

Menopause, Premature | Hysterectomy | Attitude | Perception | Ovariectomy | Estrogen Replacement Therapy

Taiwan
Sunnybrook Health Sciences Centre
Ontario Lung Association

Unknown

Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)

Premature Birth | Respiratory Insufficiency

Canada
Johann Wolfgang Goethe University Hospital

Unknown

Use of ECMO in Acute MI

ECMO and Acute MI
Shanghai Jiao Tong University School of Medicine
National Institutes of Health (NIH)

Completed

Therapeutic Effects of Berberine in Patients With Type 2 Diabetes

Type 2 Diabetes

China
Maastricht University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

The Effects and Cost-Effectiveness of an Integrated Multidisciplinary Approach for Psychogeriatric Patients

Memory Disorders | Delirium, Dementia, Amnestic, Cognitive Disorders

Netherlands
Indiana University School of Medicine

Terminated

Galantamine Augmentation of Escitalopram for Treatment of Depression

Depression

United States
Japan Clinical Oncology Group
Ministry of Health, Labour and Welfare, Japan

Terminated

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Non-Hodgkin's Lymphoma

Japan
Pfizer

Terminated

Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease

Parkinson Disease

Colombia, United States, Argentina, Puerto Rico
University Medicine Greifswald
German Federal Ministry of Education and Research

Completed

Brief Alcohol Intervention in General Hospitals

Alcohol Dependence | Alcohol Abuse | At-Risk-Drinking | Heavy Episodic Drinking
Sheba Medical Center

Unknown

The Usefulness of HyperQ Recordings for the Early Diagnosis of Acute Coronary Syndrome in Patients Presenting With Chest Pain

Acute Coronary Syndrome

Israel
National Cancer Center, Korea

Completed

Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome

Postoperative Complications | Acute Respiratory Distress Syndrome | Acute Lung Injury

Korea, Republic of
Eunice Kennedy Shriver National Institute of Child...

Completed

Occupational Therapy to Treat Children Who Over or Under React to Their Environment

Sensory Disorders

United States
Innovative Medical

Completed

Ketorolac vs. Steroid in the Prevention of CME

Cataract

United States

Search clinical trials for: Tobacco use disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations